The Board decides to amend the upper ceiling amounts for the three Round 10 consolidated proposals listed below:
|Country/ Disease Component||Amended Phase 1 Upper ceiling (2 years)(US$)||Amended Lifetime Upper ceiling (Up to 5 Years) (US$)|
|Mongolia/TB, including cross-cutting HSS||5,763,691||9,124,194|
The Board approves the amended upper ceiling amounts specified above for the initial two years.
This decision does not have material budgetary implications for the 2011 Operating Expenses Budget.